Stanley Gibbons
SGI
$66.11
-3.11%
Somnigroup International Inc. is a global bedding company that designs, manufactures, and retails sleep solutions under well-known brands such as Tempur-Pedic, Sealy, and Stearns & Foster, operating in the furnishings and appliances industry. As the parent of Mattress Firm and with a presence in over 100 countries, it holds a leading position in the mattress market, leveraging a vertically integrated omnichannel platform. The current investor narrative centers on the company's post-acquisition integration of Mattress Firm, which has expanded its retail footprint but also increased leverage, while recent quarterly results show strong revenue growth and margin recovery, though the stock has faced significant volatility and a year-to-date decline amid broader market concerns.…
SGI
Stanley Gibbons
$66.11
Related headlines
Investment Opinion: Should I buy SGI Today?
Based on the analysis, SGI is rated a Buy. The company is executing a successful turnaround, with Q1 2026 revenue growing 12.26% YoY and net income turning positive, while the forward PE of 18.57x is reasonable given expected EPS of $5.59. The analyst consensus is Strong Buy with an average target of $91.89, implying 31.5% upside, and the company generates strong free cash flow of $736.8M TTM.
Sign up to view all
SGI 12-Month Price Forecast
The AI assessment is bullish on SGI, driven by strong revenue growth, margin recovery, and a reasonable forward valuation. The company's successful integration of Mattress Firm is evident in the Q1 2026 results, and the analyst community is highly optimistic. However, the high debt level and stock underperformance warrant caution. The stance would be upgraded to high confidence if the company delivers another quarter of double-digit revenue growth and margin expansion, while a downgrade would occur if revenue growth decelerates or if the company faces liquidity issues.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Stanley Gibbons's 12-month outlook, with a consensus price target around $91.89 and implied upside of +39.0% versus the current price.
Average Target
$91.89
0 analysts
Implied Upside
+39.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$66 - $105
Analyst target range
Analyst coverage is moderate with 9 analysts, and the consensus recommendation is 'Strong Buy' with a mean rating of 1.4 (where 1 is Strong Buy and 5 is Sell). The average target price is $91.89, implying an upside of approximately 31.5% from the current price of $69.87. The distribution is bullish, with no sell ratings, and recent actions include upgrades from Jefferies (Hold to Buy) and reaffirmations from UBS and Truist Securities, indicating positive sentiment.
Bulls vs Bears: SGI Investment Factors
Somnigroup International presents a compelling turnaround story with strong revenue growth, margin expansion, and a bullish analyst consensus, but it is burdened by high leverage and a stock that has significantly underperformed the market. The bull case rests on successful integration of Mattress Firm, which has already driven a 12.26% revenue increase and a return to profitability, while the bear case centers on the sustainability of this growth given the high debt load and consumer cyclicality. The most critical tension is whether the company can continue to deliver on its earnings recovery promises to justify the forward PE of 18.57x, or if macroeconomic headwinds and integration issues will derail the turnaround. Currently, the evidence slightly favors the bulls, as the forward valuation is reasonable and analysts see significant upside, but the stock's price action suggests the market remains skeptical.
Bullish
- Strong Revenue Growth from Mattress Firm: Q1 2026 revenue grew 12.26% YoY to $1,801.5M, driven by the Mattress Firm acquisition, which expanded retail footprint and omnichannel capabilities. This growth is expected to continue, with analysts projecting FY2026 revenue of $8.80B, up from TTM revenue of $7.67B.
- Margin Recovery and Profitability: Gross margin improved from 36.2% in Q1 2025 to 43.6% in Q1 2026, and operating margin rose from 0.8% to 11.5% YoY. Net income turned positive at $104.2M in Q1 2026 versus a loss of $33.1M in the prior year, demonstrating successful integration and cost synergies.
- Analyst Consensus Strong Buy: With 9 analysts, the consensus rating is 'Strong Buy' (mean 1.4), and the average target price is $91.89, implying 31.5% upside from the current price of $69.87. No sell ratings exist, and recent upgrades from Jefferies and reaffirmations from UBS and Truist signal positive sentiment.
- Attractive Forward Valuation: The forward PE of 18.57x is reasonable given expected EPS growth to $5.59 (analyst estimate) for FY2026, implying a forward PEG of ~1.0. This suggests the stock is fairly valued relative to its growth prospects, especially compared to the trailing PE of 48x, which reflects past earnings trough.
Bearish
- High Debt Levels Post-Acquisition: Debt-to-equity ratio is 2.66, reflecting significant leverage from the Mattress Firm acquisition. Interest expense was $60M in Q1 2026, and while manageable, high debt increases financial risk, especially if revenue growth stalls or interest rates remain elevated.
- Stock Underperforming Market: The stock is down 19.58% over the past year, while the S&P 500 gained 18.65%, a relative underperformance of 38.2%. Year-to-date, the stock is down 21.26%, indicating persistent selling pressure and negative investor sentiment.
- High Trailing PE and Negative PEG: The trailing PE of 48x is elevated, and the PEG ratio is -3.03 due to past losses. This suggests that the market is pricing in a significant earnings recovery, and any shortfall could lead to multiple compression and further downside.
- Integration Risks and Seasonality: Revenue has been uneven, with Q3 2025 revenue of $2,122.6M being the highest, while Q1 2026 was lower at $1,801.5M. Integration challenges with Mattress Firm could disrupt operations, and the company's dependence on consumer discretionary spending makes it sensitive to economic downturns.
SGI Technical Analysis
The stock is in a clear downtrend over the past year, with a 1-year price change of -19.58%, significantly underperforming the S&P 500's +18.65% gain. Currently trading at $69.87, the stock is near the lower end of its 52-week range, at approximately 71% of the range (from low of $60.39 to high of $98.56), indicating bearish sentiment and potential value or further downside risk. The 52-week low of $60.39 was tested in August 2026, and the stock has since bounced, but the overall trend remains downward.
Beta
1.19
1.19x market volatility
Max Drawdown
-37.3%
Largest decline past year
52-Week Range
$60-$99
Price range past year
Annual Return
-22.3%
Cumulative gain past year
| Period | SGI Return | S&P 500 |
|---|---|---|
| 1m | +1.3% | -1.6% |
| 3m | -8.5% | +2.2% |
| 6m | -14.1% | +14.4% |
| 1y | -22.3% | +16.2% |
| ytd | -25.5% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SGI Fundamental Analysis
Revenue has shown strong growth, with the most recent quarter (Q1 2026) reporting $1,801.5 million, a 12.26% YoY increase, and sequential growth from $1,604.7 million in Q1 2025. This growth is driven by the inclusion of Mattress Firm, which has significantly expanded the company's retail presence. However, revenue growth has been uneven, with Q3 2025 revenue of $2,122.6 million being the highest in recent quarters, indicating some seasonality and potential integration challenges. The company's trailing twelve-month revenue is approximately $7.67 billion, and analysts expect revenue of $8.80 billion for the current fiscal year, implying continued growth.
Quarterly Revenue
$1.8B
2026-03
Revenue YoY Growth
+12.3%
YoY Comparison
Gross Margin
43.6%
Latest Quarter
Free Cash Flow
$736800000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SGI Overvalued?
Given that net income is positive (TTM net income of $489 million), the PE ratio is the primary valuation metric. The trailing PE is 48.0x, while the forward PE is 18.57x, indicating that the market expects significant earnings growth in the next year. This large gap suggests that the market is pricing in a substantial recovery in earnings, likely from the Mattress Firm acquisition synergies and operational improvements. The forward PE of 18.57x is more reasonable for a company with expected EPS growth of 5.59 (analyst estimate) versus current EPS of 0.50 (quarterly), implying a PEG ratio of -3.03 (negative due to past losses), but the forward PEG (using forward PE and growth) would be around 1.0, which is fair.
PE
48.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 16x~37x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are elevated due to the company's high leverage, with a debt-to-equity ratio of 2.66 and interest expenses of $60M in Q1 2026. While free cash flow of $736.8M TTM provides some cushion, the current ratio of 0.83 indicates potential liquidity stress if cash flows deteriorate. The company's revenue growth is heavily dependent on the successful integration of Mattress Firm, and any operational missteps could lead to margin compression and earnings shortfalls. Additionally, the trailing PE of 48x implies that the market expects substantial earnings growth, and any disappointment could trigger a sharp de-rating.
FAQ
The key risks of holding SGI include: 1) Financial risk from high leverage (debt-to-equity of 2.66) and interest expenses of $60M per quarter, which could strain cash flows if revenue declines. 2) Integration risk with Mattress Firm, which could lead to operational disruptions and higher costs. 3) Market risk from the stock's high beta of 1.189, making it more volatile than the market, and its underperformance (down 19.58% over the past year). 4) Macroeconomic risk from consumer spending sensitivity to interest rates and economic cycles, as mattresses are discretionary purchases. The most severe risk is a prolonged economic downturn that could reduce revenue and trigger a de-rating of the stock.
The 12-month forecast for SGI is cautiously optimistic, with a base case probability of 50% for a target range of $80-$92, aligning with the analyst average of $91.89. The bull case (30% probability) targets $91.89-$105, driven by strong execution and market tailwinds, while the bear case (20% probability) targets $60.39-$70, reflecting potential headwinds. The most likely scenario is the base case, which assumes continued revenue growth of 10-12% and successful integration. Investors should monitor quarterly earnings for signs of margin expansion and debt reduction to confirm the forecast.
Based on the forward PE of 18.57x, SGI appears fairly valued relative to its expected earnings growth of $5.59 per share, implying a PEG ratio of approximately 1.0. The trailing PE of 48x is high, but this reflects the past earnings trough and is not indicative of future valuation. Compared to the broader market, the forward PE is in line with the S&P 500 average, suggesting the stock is not overvalued. However, the high debt level and integration risks warrant a discount, so the stock could be considered slightly undervalued if the company meets its earnings targets.
SGI appears to be a good buy for investors with a medium-to-long-term horizon, given the strong revenue growth of 12.26% YoY in Q1 2026 and the potential for earnings recovery. The analyst consensus is Strong Buy with an average target of $91.89, implying a 31.5% upside from the current price of $69.87. However, the stock carries significant risk due to high leverage (debt-to-equity of 2.66) and its underperformance relative to the market. It is a good buy for those who believe in the Mattress Firm integration story and can tolerate volatility, but it may not be suitable for risk-averse investors.
SGI is more suitable for long-term investment (3-5 years) given its turnaround nature and the time required to fully realize the benefits of the Mattress Firm acquisition. The stock has high volatility (beta of 1.189) and has underperformed the market, making it risky for short-term trading. The company's earnings visibility is improving, but the high debt level and integration risks suggest that patience is needed. A minimum holding period of 3 years is recommended to allow the company to deleverage and achieve sustained earnings growth, which could lead to a re-rating of the stock.